Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation

The success of allogeneic hematopoietic cell transplantation (HCT) is typically assessed as individual complications, including graft-versus-host disease (GVHD), relapse, or death, yet no one factor can completely characterize cure without ongoing morbidity. We examined a novel composite end point o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Holtan, Shernan G., DeFor, Todd E., Lazaryan, Aleksandr, Bejanyan, Nelli, Arora, Mukta, Brunstein, Claudio G., Blazar, Bruce R., MacMillan, Margaret L., Weisdorf, Daniel J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2015
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335084/
https://ncbi.nlm.nih.gov/pubmed/25593335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-10-609032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados